Concord Medical Services (CCM)
(Delayed Data from NYSE)
$6.05 USD
+0.57 (10.40%)
Updated Sep 24, 2024 03:58 PM ET
After-Market: $6.07 +0.02 (0.33%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CCM 6.05 +0.57(10.40%)
Will CCM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CCM
Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts
Canagold Announces Promising Drilling Results at New Polaris
Concord Medical secures large medical equipment procurement license for proton therapy equipment
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
Concord Medical Secures Key Equipment License